Medivation has jumped nearly 25% to $69.12 after posting a new 52-week high of $70.87 earlier today. The development stage drug maker has reported highly positive results on a test of its late-stage prostate cancer treatment. We have more coverage here.

Live Deal is up nearly 25% at $5.47. The customer acquisition company got a capital infusion on Monday from the private equity division of Isaac Organization.

RadiSys is up nearly 22% at $7.35 in a 52-week range of $4.01-$9.38. The company has announced a ruggedized version of a Core processor from Intel Corp. (NASDAQ: INTC).

Savient is down more than 12% at $2.22. The drug company lost its CEO, who has joined Dendreon Corp. (NASDAQ: DNDN) as its new CEO.

Vringo is down nearly -6% at $1.32. The social media company is giving back some of the 30% gain it enjoyed yesterday.

The DJIA is up 1% at around 12,760, the S&P 500 is up 1.19% at about 1,328, and the Nasdaq Composite is up 1.33% at about 2,851.

Paul Ausick

Amazon.com Inc. (NASDAQ: AMZN) Cut to Neutral at UBS.
Berkshire Hathaway Inc. (NYSE: BRK-B) Raised to Hold at Stifel Nicolaus.
Comcast Corporation (NASDAQ: CMCSA) Started as Buy at Goldman Sachs.
Frontier Oil Corp. (NYSE: FTO) Raised to Equal-Weight at Barclays.
Potash Corp. of Saskatchewan (NYSE: POT) Raised to Buy at Gleacher & Co.; Maintained Outperform at Credit Suisse.
Savient Pharmaceuticals Inc. (NASDAQ: SVNT) Maintained Underperform at BofA/ML.
Seagate Technology PLC (NYSE: STX) Cut to Underweight at JPMorgan.
Tenet Healthcare Corporation (NYSE: THC) Raised to Buy at UBS.

You can join our free daily email distribution list to hear more about analyst upgrades and downgrades, top day trader and active trader alerts, dividend trends, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Annaly Capital Management, Inc. (NYSE: NLY) Cut to Hold at Jefferies.
Apple Inc. (NASDAQ: AAPL) Raised target to $438 at Kaufman Bros; Reiterated Buy with $375 target at Needham; Oppenheimer raised target to $425.
The Blackstone Group (NYSE: BX) Raised to Buy at Jefferies.
Bunge Ltd. (NYSE: BG) Raised to Outperform at Credit Suisse.
Citigroup Inc. (NYSE: C) Cut estimates for 2011 and 2012 at BofA/ML.
Comerica Incorporated (NYSE: CMA) Raised to Hold at Citigroup.
Cree Inc. (NASDAQ: CREE) Kept at Hold but lowered target to $52 at Kaufman Bros.
Cypress Semiconductor Corporation (NASDAQ: CY) Raised to Buy at UBS.
DryShips, Inc. (NASDAQ: DRYS) Started as Neutral at Stern Agee.
Archer Daniels Midland Company (NYSE: ADM) Raised to Outperform at Credit Suisse.
McDonald’s Corporation (NYSE: MCD) Added to Focus List at Credit Suisse.
Merck & Co. Inc. (NYSE: MRK) Started as Outperform at Wells Fargo.
Pfizer Inc. (NYSE: PFE) Started as Outperform at Wells Fargo.
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) Cut to Underperform at BofA/ML.
United States Steel Corp oration (NYSE: X) Raised to Buy at Deutsche Bank.

You can join our free daily email distribution list to hear more about analyst upgrades and downgrades, top day trader and active trader alerts, dividend trends, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

AngloGold Ashanti Ltd. (NYSE: AU) was down 4.5% at $44.62 on over 500,000 shares after a mine accident closed down a mine after a worker’s death.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is down after its weight loss drug candidate is in trouble.  Shares are down 6.8% at $3.85 on over 200,000 shares.

Beazer Homes USA Inc. (NYSE: BZH) is down after saying that it might miss order expectations this quarter and cut estimates for the year on land costs.  Shares are down 4.6% at $4.33 on thin volume.

Harbor BioSciences, Inc (NASDAQ: HRBR) is soaring by 60% at $0.38 after its prostate cancer drug shows partial overall response.

Level 3 Communications Inc. (NASDAQ: LVLT) is recovering after pricing its $175 million 6.5% Convertible Senior Notes due 2016 with an initial conversion price of $1.235 per share.  Shares were hit yesterday but the stock is up 4.25 at $0.99 on recovery mode after an obvious Over-Sale yesterday.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is down after its major depressive disorder drug candidate was ineffective.  Shares were down by 9.6% at $5.65 on more than 300,000 shares last night and shares are trading around $5.67 on last look this morning.

Novell, Inc. (NASDAQ: NOVL) is up on word that it may sell the company in two parts; sshares are up 6% around $5.90 on close to 1 million shares.

Savient Pharmaceuticals Inc. (NASDAQ: SVNT) is soaring after the FDA finally approvedits gout drug, about a year or two later than many expected.  Shares are up 27% at $18.81 on more than 1 million shares.

UTStarcom, Inc. (NASDAQ: UTSI) is up 7.25% at $2.07 after the company announced a contract from Jinan, Shandong Province to accelerate its network transformation and integration.

Radware Ltd. (NASDAQ: RDWR) was yesterday’s big rumor move higher but shares are down slightly this morning.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Air Products & Chemicals (NYSE: APD) Started as Outperform at William Blair.
Akamai Technologies, Inc. (NASDAQ: AKAM) Raised to Buy at Citigroup.
First Solar Inc. (NASDAQ: FSLR) Raised to Buy at Collins Stewart.
Mastercard Incorporated (NYSE: MA) Started as Outperform at Oppenheimer.
The McGraw-Hill Companies, Inc. (NYSE: MHP) Started as Buy at BofA Merrill Lynch.
Moody’s Corp. (NYSE: MCO) Started as Buy at BofA Merrill Lynch.
Netflix, Inc. (NASDAQ: NFLX) Cut to Hold at Citigroup.
Savient Pharmaceuticals (NASDAQ: SVNT) Started as Overweight at JPMOrgan.
Under Armour (NYSE: UA) Started as Buy at Jefferies.
Visa, Inc. (NYSE: V) Started as Outperform at Oppenheimer.

You can join our open email distribution list to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Acorda Therapeutics, Inc. (NASDAQ: ACOR) down on FDA link that made its data public.

AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) is the top gainer so far as Zenvia data showed positive results at higher doses.

Infosys Technologies Limited (NASDAQ: INFY) beat earnings, but shares are down about 3%.

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) is trading up over 4% after a secondary offering, and an upgrade probably helped here.

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is down sharply on complete response letter from FDA for FUSILEV in advanced metastatic colorectal cancer going against it.

Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE: TSM) is up marginally on over 1 million shares a sales drop still met plan.

You can join our open email distribution list to get updates each morning on analyst upgrades and downgrades, top day trader alerts, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG
October 9, 2009

Paramount Gold & Silver (AMEX: PZG) is taking advantage of higher gold prices.  The company priced a 16 million shares secondary offering of common stock at $1.25 through Dahlman Rose and Blackmont Capital.

Savient Pharmaceuticals (NASDAQ: SVNT) priced a 4.4 million share secondary offering of common stock at $13.29 per share in a sale through J.P. Morgan and Wedbush Morgan. The deal size was increased from 4M shares on what was believed to be higher demand, and this one closed at $13.29 yesterday.

GOL Linhas Aereas Inteligentes SA (NYSE: GOL) raised roughly $590 million in a GDR offering of 62.19 million shares at BRL 16.50 per share through Itau BBA, Morgan Stanley, Bradesco BBI, BB Investimentos, and Bank of America Merrill Lynch.

JON C. OGG
October 9, 2009

AK Steel (AKS) Raised to Buy at Deutsche Bank.
Bristol-Myers (BMY) Started as Outperform at Wells Fargo.
Cree (CREE) Started as Overweight at JPMorgan
J.P. Morgan (JPM) Started as Strong Buy at Raymond James.
Lam Research (LRCX) Raised to Outperform at Credit Suisse.
Marriott (MAR) Raised to buy at BofA/Merrill Lynch.
Research in Motion (RIMM) Raised to Outperform at R.W. Baird.
Savient Pharma (SVNT) Raised to Outperformat Oppenheimer.
Spectra Energy (SE) Raised to Conviction Buy List at Goldman Sachs.
Viacom (VIA) Raised to Overweight at Piper Jaffray.

You can join our open email distribution list to get updates each morning on analyst upgrades and downgrades, top day trader alerts, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG
October 9, 2009

Barrick Gold (ABX) Cut to Sector Perform at CIBC.
Big 5 Sports (BGFV) Raised to Neutral from Underweight at Piper Jaffray.
Digital Realty Trust (DLR) Cut to Hold at KeyBanc.
DISH Network (DISH) Raised to Outperform at CRedit Suisse.
Hologic (HOLX) Cut to Hold at Citigroup.
Human Genome (HGSI) Raised to Buy at ThinkEquity.
Myriad Genetics (MYGN) Started as Outperform at William Blair.
Pharmerica (PMC) Cut to Perform at Oppenheimer.
Savient Pharma (SVNT) Cut to Underperform at Jefferies.
Talbots (TLB) Raised to Outperform at FBR.

JON C. OGG
AUGUST 4, 2009

Savient Pharmaceuticals (NASDAQ: SVNT) is among the worst performers on disappointing FDA action on its gout treatment.

Huron Consulting Group Inc. (NASDAQ: HURN) is the worst performer on earnings restatements and management being replaced.

Repros Therapeutics (NASDAQ: RPRX) is down sharply by over 50% after stopping trials on patient safety.

eBay Inc. (NASDAQ: EBAY) is up over 4% after getting the barron’s cover story.

Humana Inc. (NYSE: HUM) is up over 4% on higher earnings growth.

Oncothyreon Inc. (NASDAQ: ONTY) is up big on lung cancer study data.

The 24/7 Wall St. Team